DAE HWA Pharmaceutical Co. Ltd (067080) — Long-term Investment Intensity
DAE HWA Pharmaceutical Co. Ltd (067080) has a Long-term Investment Intensity of 10.9% as of September 2019. Long-term investments of ₩19.11 Billion represent 10.9% of total assets of ₩175.79 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does DAE HWA Pharmaceutical Co. Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
DAE HWA Pharmaceutical Co. Ltd Long-term Investment Intensity (2014–2018)
This chart shows how DAE HWA Pharmaceutical Co. Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of September 2019, the intensity stands at 10.9%, reflecting long-term investments of ₩19.11 Billion against total assets of ₩175.79 Billion KRW. Explore DAE HWA Pharmaceutical Co. Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for DAE HWA Pharmaceutical Co. Ltd (2014–2018)
The table below presents the year-by-year Long-term Investment Intensity for DAE HWA Pharmaceutical Co. Ltd from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see DAE HWA Pharmaceutical Co. Ltd stock valuation.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 8.5% | ₩13.71 Billion | ₩162.06 Billion | ▼ -1.2 pp |
| 2017 | 9.7% | ₩16.00 Billion | ₩165.47 Billion | ▲ +4.8 pp |
| 2016 | 4.9% | ₩7.55 Billion | ₩153.80 Billion | ▼ -0.6 pp |
| 2015 | 5.5% | ₩6.80 Billion | ₩124.61 Billion | ▲ +1.4 pp |
| 2014 | 4.1% | ₩5.09 Billion | ₩124.07 Billion | — |